These findings suggest that LS exerts its anti-tumor effects by simultaneously enhancing ROS generation, inhibiting the PI3K/AKT/GSK-3β pathway, and restraining HepG2 cell proliferation. This evidence concerns the gene AKT1 and neoplasm.